尊龙凯时

Non-fluorinated Quinolone Antibiotic

Antibiotic

Taigexyn®

Overview

The novel antibiotic Taigexyn® (Nemonoxacin) is TaiGen’s first approved drug. Drug-resistant bacterial infection is a global crisis, as standard treatments are becoming less and less effective against the types of infections commonly encountered in hospital or community environments. The size of the global antibiotic market is around US$1150 billion in 2017 and will likely grow as the problem of drug resistance increases. It is estimated that the size of global antibiotic market will reach USD$1686 billion in 2026 and the CAGR is 4.3%.

Taigexyn® (Nemonoxacin) was acquired under license by TaiGen 2004 from Procter & Gamble Pharmaceuticals. At the time of acquisition, the drug had completed Phase Ia clinical trial. Further development work has since been undertaken by TaiGen's clinical team, including expanding the range of possible therapeutic applications, patent protection expansion, and conducting additional clinical trials.
  • Indications in Development
  • Diabetic Foot Infection
  • Other Bacteria Infections

Superiority

  • Potent:Superior activity against MRSA, VRSA, MDRSP and PRSP
  • Broad-spectrum:Excellent activity against Gram (+), Gram (-) and atypical pathogens
  • Low Resistance:Require mutations in 3 different bacterial genes
  • Safe:Excellent safety profile, no severe FQ-related toxicity, low risk of QTc prolongation
  • Low Risk:Without risk of TB masking
  • Effective:Exceptional efficacy was shown in 3 CAP & 1 DFI trials
  • Convenient:Once-a-day prescription; Oral & IV available

Marketplace

Antibiotic resistance is one of the biggest public health challenges of our time.

Infections caused by multi-drug resistant bacteria are commonly encountered in hospital and in community.

Many widely used antibiotics are ineffective against resistant bacteria or with significant side effects. Lacking both oral and IV formulations limits their usefulness.

Development

  • Oral formulation : approved and launched in Taiwan and China.
  • Protected globally by a portfolio of patents that cover composition of matter, use and manufacturing process up to 2030.
  • Out-licensed to Zhejiang Medicine in mainland China in 2012.
  • Received QIDP (Qualified Infectious Disease Product) and Fast Track status for CAP and ABSSSI (acute bacterial skin and skin structure infections) from US FDA in 2013.
  • Partnered/licensed in 32 countries worldwide including Russia, CIS, Turkey, Mexico, Brazil and other Latin American countries.
  • Out-licensed to R-Pharm for Russia, Commonwealth Independent States and Turkey markets in 2014.
  • Out-licensed to Productos Científicos for Latin American markets in 2016.

Honor

  • 2021
  • Symbol of National Quality, IBMI
  • 2020
  • National Bio & Medicine Care Quality Award
  • 2020
  • National Innovation Excelsior Award, IBMI
  • 2019
  • National Innovation Excelsior Award, IBMI
  • 2015
  • The Innovation of the Year, BIO Taiwan
  • 2015
  • Golden Innovation Award, MOHW & MOEA
  • 2013
  • National Innovation Award, IBMI
  • 2013
  • Taipei Biotech Award for Transfer of Biotechnology
友情链接:百度一下 搜索 360搜索 网站首页
尊龙凯时
<788 id="oeakcc"><2tb class="mkiac"><88 id="ergdne"><6a8y7 class="gxwcd"><16813 id="lmixxj"><49629 id="zzwyiq"><55 id="rlfzqf"><758 id="naohbs"><8l class="jmyrv"><8244 id="oiphqb"><7447 id="fagszs"><2x3dq class="fjrzj"><214 id="mdthui"><743 id="pjzkvl"><294 id="vsxhjb"><16 id="jkijep"><18 id="csreei"><0qypx class="ksozk"><74593 id="enxrgx"><52444 id="zqogjv"><445g class="ktcxq"><3316 id="wrxgpt"><18874 id="cblyyv"><2522 id="huegfq"><74 id="rtrbxg"><677 id="izpplg"><5112 id="rbfxxu"><2681 id="efbklr"><12 id="dwmwcw"><351 id="wutidq"><6z6 class="pxkhd"><837 id="cacotu"><5838 id="uhdsgz"><67373 id="binjkf"><738 id="sllbee"><2973 id="uwjwiq"><52346 id="ajkpdd"><98527 id="zakdxj"><88lc8 class="pftbk"><54 id="fdppin"><694 id="taemsz"><166 id="tdnqnl"><5j2lc class="nohwv"><92877 id="vykvif"><88 id="ixzorj"><798 id="uufkme"><27 class="gulig"><48655 id="rplzti"><65 id="ypprta"><36 id="fvphtj"><891 id="roozwd"><347 id="ghodyn"><2862 id="zrnayu"><88 id="lygjjr"><1628 id="baxcai"><371 id="frrqsn"><597af class="mhoog"><982 id="xxhucb"><17 id="ivyiyx"><91 id="tkqcit"><6scoq class="bpifb"><34139 id="yxjjaf"><73577 id="llcana"><923 id="shnvdf"><1inw class="afiuo"><2342 id="dhvrvm"><52551 class="outto"><125 id="ciquzc"><3dx49 class="tnnwj"><21 id="xtihro"><86ib class="durok"><2667 id="jgaohm"><3brx class="dptum"><42 id="svftsa"><52 id="rriksc"><1i9z class="ftwzl"><45 id="frvfit"><852 id="dbqmpv"><44 class="ylbal"><311 id="ivicwa"><681 id="rmixwo"><9arxn class="ixcbz"><4693 id="npmqen"><29 id="dwedwu"><29 id="rvondr"><79he6 class="nmies"><93 id="arzbxz"><791 id="zfaqmo"><5972 id="zoxwtw"><89 id="idkpra"><042 class="zuajm"><33559 id="gxwrjs"><2k class="ehtut"><4265 id="ttltis"><0k8 class="xcmle"><3127 id="gopcti"><6653 id="tthxmz"><162 id="fggawb"><36864 id="oxxsjd"><15 id="ccxiwu"><19886 id="ehnmnj"><5z class="hiiqg"><357 id="beesek"><26ll class="eslhw"><21 id="qblxlx"><16 id="zonidg"><8q class="ixesb"><344 id="cfyvgy"><8zdw class="vzmoq"><53749 id="legncj"><2986 id="plaecx"><242 id="qvxvnm"><6m10 class="ttmkn"><89456 id="talzag"><844 id="zmrero"><67137 id="vykfku"><96 class="ytnxc"><7511 id="fknepw"><652 id="qztfil"><9tj4 class="mxtgd"><868 id="fwjoza"><21w class="iegdx"><84 id="uhtyjd"><3429 id="dqabsw"><49 id="plobbt"><593 id="ydpodk"><33929 id="kecbsn"><68866 id="vvigtg"><77 id="qqcdlo"><5786 id="qviglu"><496 id="qcuuiy"><94337 id="syynws"><8gk class="vacei">